Volume 54, Issue 4, Pages (October 2008)

Slides:

Advertisements

Similar presentations

Volume 60, Issue 4, Pages (October 2011)

Advertisements

Volume 61, Issue 3, Pages (March 2012)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Response to Nivolumab in a Patient With Metastatic Clear Cell Renal Cell Carcinoma and End-stage Renal Disease on Dialysis Maria I. Carlo, Darren R.

Volume 55, Issue 2, Pages (February 2009)

Volume 62, Issue 4, Pages (October 2012)

Testosterone Therapy in Men With Prostate Cancer

Volume 68, Issue 6, Pages e129-e131 (December 2015)

Volume 57, Issue 3, Pages e22-e23 (March 2010)

Volume 61, Issue 5, Pages (May 2012)

Volume 53, Issue 4, Pages (April 2008)

Volume 69, Issue 1, Pages 4-6 (January 2016)

Lymph Node Dissection in Renal Cell Carcinoma

Volume 63, Issue 3, Pages e39-e40 (March 2013)

Volume 71, Issue 6, Pages e171-e172 (June 2017)

Bladder Cancer: Management and Future Directions

New Research on Kidney Cancer: Highlights from Urologic and Oncologic Congresses in 2006 Jean-Jacques Patard, Eric Lechevallier, Belén Congregado Ruiz,

Let the Games Begin (with EAU Approval)

Volume 63, Issue 6, Pages (June 2013)

Volume 50, Issue 5, Pages (November 2006)

Volume 63, Issue 4, Pages e53-e56 (April 2013)

Daily Administration of Phosphodiesterase Type 5 Inhibitors for Urological and Nonurological Indications Anthony J. Bella, Ling X. DeYoung, Mussa al-Numi,

Nomograms for Bladder Cancer

Precystectomy Nomogram for Prediction of Advanced Bladder Cancer Stage

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 67, Issue 2, Pages (February 2015)

Volume 54, Issue 4, Pages (October 2008)

Volume 52, Issue 5, Pages (November 2007)

Cost Effectiveness of Nivolumab in Advanced Renal Cell Carcinoma

Volume 57, Issue 4, Pages (April 2010)

Volume 68, Issue 1, Pages (July 2015)

Volume 57, Issue 4, Pages e41-e42 (April 2010)

International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia Brett Delahunt, John R. Srigley, Lars Egevad,

Volume 52, Issue 4, Pages (October 2007)

Volume 50, Issue 3, Pages (September 2006)

Volume 59, Issue 3, Pages e7-e8 (March 2011)

Volume 70, Issue 1, Pages e27-e28 (July 2016)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 54, Issue 4, Pages (October 2008)

Volume 51, Issue 5, Pages (May 2007)

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Reply to Taimur T. Shah, Graeme MacLennan, Rob Pickard, Samuel McClinton and Veeru Kasivisvanathan's Letter to the Editor re: Zhangqun Ye, Guohua Zeng,

Volume 68, Issue 6, Pages e134-e135 (December 2015)

Volume 59, Issue 1, Pages (January 2011)

Volume 60, Issue 6, Pages (December 2011)

Volume 56, Issue 5, Pages (November 2009)

Training in Percutaneous Nephrolithotomy—A Critical Review

Tyrosine Kinase Inhibitors in Clinical Practice: Patient Selection

Volume 50, Issue 5, Pages (November 2006)

Mammalian Target of Rapamycin Inhibitors in Clinical Practice: Case Reports of Everolimus in Renal Cell Carcinoma Sergio Bracarda, Alain Ravaud, Marino.

Volume 55, Issue 3, Pages (March 2009)

Testicular Cancer Variations in Time and Space in Europe

Volume 54, Issue 4, Pages (October 2008)

Sergio Bracarda European Urology Supplements

European Urology is “Your” Journal

Epidemiology of Renal Cell Carcinoma

Volume 51, Issue 6, Pages (June 2007)

Volume 50, Issue 5, Pages (November 2006)

Volume 54, Issue 1, Pages (July 2008)

Prognostic Factors in Non–Muscle-Invasive Bladder Tumors

Volume 53, Issue 6, Pages (June 2008)

Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma Jan Roigas European Urology Supplements Volume.

Annika Berntsen, Poul F. Geertsen, Inge Marie Svane European Urology

Radiofrequency Ablation of Metastases from Renal Cell Carcinoma: Technique, Complications, and Midterm Outcome Christian Kloeters, Ann-Kathrin Mager,

Bertrand Tombal, Richard Berges

Joaquim Bellmunt European Urology Supplements

Jan Roigas European Urology Supplements

Volume 54, Issue 1, Pages (July 2008)

Volume 163, Issue 2, (October 2015)

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 54, Issue 4, Pages 951-953 (October 2008) Reply to Michael Staehler's Letter to the Editor re: Pierre I Karakiewicz, Nazareno Suardi, Claudio Jeldres, et al. Neoadjuvant Sutent Induction Therapy May Effectively Down-Stage Renal Cell Carcinoma Atrial Thrombi. Eur Urol 2008;53:845-848 Claudio Jeldres, Umberto Capitanio, Nazareno Suardi, Paul Perrotte, Jean-Jacques Patard, Pierre Karakiewicz European Urology Volume 54, Issue 4, Pages 951-953 (October 2008) DOI: 10.1016/j.eururo.2008.04.104 Copyright © 2008 European Association of Urology Terms and Conditions

Fig. 1 CT scan of the chest demonstrating absence of metastases at 10 mo of follow-up. European Urology 2008 54, 951-953DOI: (10.1016/j.eururo.2008.04.104) Copyright © 2008 European Association of Urology Terms and Conditions